Xeris Biopharma Holdings, Inc. (XERS) insider trading

By person

15 insiders · 3 transactions

39.9×

John Shannon holds 39.9 times base salary in stock. $29.66M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $10.23, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Beth Hecht

See Remarks

—

$255.83K (1) scheduled

−$255.83K

1,086,130

0.5957%

$11.11M

−21.9%

Kevin McCulloch

See Remarks

—

$153.49K (1) scheduled

−$153.49K

1,609,208

0.8826%

$16.47M

−1.9%

Steven Pieper

See Remarks

—

$51.17K (1) scheduled

−$51.17K

1,346,053

0.7383%

$13.77M

−5.5%

John Patrick Shannon Jr

See Remarks

—

2,898,933

1.59%

$29.66M

+34.5%

John Johnson

Director

—

707,276

0.3879%

$7.24M

−20.6%

Anh Tu Nguyen

See Remarks

—

395,023

0.2167%

$4.04M

+30.4%

Kenneth Erland Johnson

See Remarks

—

320,446

0.1758%

$3.28M

−14.4%

Garheng Kong

Director

—

238,337

0.1307%

$2.44M

+45.2%

Jeffrey W Sherman

Director

—

219,188

0.1202%

$2.24M

+33.3%

Marla Persky

Director

—

150,693

0.0827%

$1.54M

+40.2%

Barbara-Jean Anne Bormann-Kennedy

Director

—

150,693

0.0827%

$1.54M

+40.2%

Dawn Halkuff

Director

—

119,193

0.0654%

$1.22M

+10.9%

James Aloysius Brady

Director

—

113,359

0.0622%

$1.16M

—

Nerissa Kreher

Director

—

33,582

0.0184%

$343.63K

—

Menassie Taddese

Director

—

22,365

0.0123%

$228.85K

—

Xeris Biopharma Holdings, Inc.

What the insiders did Scheduled selling only

By person